Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Immunogenicity and Safety of the Recombinant Adjuvanted Herpes Zoster Vaccine in Patients with Chronic Lymphocytic Leukemia and Multiple Myeloma

Christina-Nefeli Kontandreopoulou, Christos Stafylidis, Vassiliki Labropoulou, Stavroula Smilakou, Dimitra Vlachopoulou, Iraklis Patsialos, Stavroula Syriopoulou, Alexandros Gkikas, Eleftherios N. Athanasopoulos, Anastasios Vogiatzakis, Eleni Panousi, Georgios Kyriakakis, Amalia Anastasopoulou, Marina Mantzourani, Panagiotis T Diamantopoulos

Blood (2024) 144 (Supplement 1): 3257.

https://doi.org/10.1182/blood-2024-202052

Published: 2024

Journal Articles

Real-Life Experience of Luspatercept in Transfusion-Dependent Lower-Risk Myelodysplastic Syndrome Patients

Blood (2024) 144 (Supplement 1): 6737.

https://doi.org/10.1182/blood-2024-202478

Published: 2024

Journal Articles

Illness Perceptions and Heath Related Quality of Life in Patients with Primary Immune Thrombocytopenia

Christina E Lekarakou, Antonios Bertsias, Panagiotis T Diamantopoulos, Marina Mantzourani, Anthi Bouchla, Sofia Chatzileontiadou, Peggy Kanellou, Athanasios Gakopoulos, George Katrinakis, Maria Psyllaki, Vasiliki Pappa, Maria Papaioannou, Dimitra Liapi, Sosana Delimpasi, Helen A Papadaki, George Koulierakis, Charalampos G Pontikoglou

Blood (2024) 144 (Supplement 1): 7692.

https://doi.org/10.1182/blood-2024-204552

Published: 2024

Journal Articles

A Single-Center Study of Long-Term Efficacy and Discontinuation Patterns of Thrombopoietin Receptor Agonists in Chronic Immune Thrombocytopenia

Christos Stafylidis, Panagiotis T Diamantopoulos, Dimitra Vlachopoulou, Vasiliki Antoniadou, Stavroula Syriopoulou, Iraklis Patsialos, Marina Mantzourani

Blood (2024) 144 (Supplement 1): 5439.

https://doi.org/10.1182/blood-2024-208230

Published: 2024

Journal Articles

The Prognostic Significance of Serum Beta-2 Microglobulin (sβ 2 m) Levels in Patients with Hodgkin Lymphoma (HL): Final Analysis on 915 Patients Treated with ABVD or Equivalent (ABVDeq) Chemotherapy or Combined Modality Therapy (CT/CMT) Focusing to the Determination of Optimal Cut-Offs

Blood (2022) 140 (Supplement 1): 12016–12017.

https://doi.org/10.1182/blood-2022-169972

Published: 2022

Journal Articles

Micrornas Analysis in Patients with Myelodysplastic Syndrome. Possible Implications in Risk Stratification

Christina-Nefeli Kontandreopoulou, Stavroula Syriopoulou, Panagiotis T Diamantopoulos, Nefeli Giannakopoulou, Dimitra Vlachopoulou, Panagiota Katsiampoura, Christos Stafylidis, Maria Dimou, Athanasios Galanopoulos, Sotirios Papageorgiou, Eleftheria Hatzimichael, Vassiliki Pappa, Kotsianidis Ioannis, Argiris Symeonidis, Panayiotis Panayiotidis, Nora-Athina Viniou

Blood (2022) 140 (Supplement 1): 6958–6959.

https://doi.org/10.1182/blood-2022-165870

Published: 2022

Journal Articles

Evidence That Platelets from Transfusion-Dependent Thalassemia Patients Induce T Cell Activation

Elena E. Solomou, Polyxeni Delaporta, Aimilia Mantzou, Marianna Tzannoudaki, Panagiotis T Diamantopoulos, Christina Salamaliki, Christina-Nefeli Kontandreopoulou, Athina Vyniou, Foteini Perganti, Ioannis Papassotiriou, Antonis Kattamis

Blood (2022) 140 (Supplement 1): 2481–2482.

https://doi.org/10.1182/blood-2022-159241

Published: 2022

Journal Articles

The Transcription Factor ETS-1 Correlates with the Increased Age Associated B Cells in Patients with Acquired Aplastic Anemia

Elena E. Solomou, Antonis Kattamis, Argiris Symeonidis, Haroula Sirinian, Christina Salamaliki, Panagiotis T Diamantopoulos, Athanasios Galanopoulos, Maria D. Palasopoulou, Christina-Nefeli Kontandreopoulou, Nikolaos Giannakoulas, Nora-Athina Viniou, Stamatis-Nick Liossis, George Vassilopoulos

Blood (2022) 140 (Supplement 1): 481–482.

https://doi.org/10.1182/blood-2022-157696

Published: 2022

Journal Articles

Myelodysplastic Syndromes (MDS) Presenting with Isolated Thrombocytopenia: Characteristics, Outcomes, and Clinical Presentation Differences from Immune Thrombocytopenic Purpura (ITP)

Blood (2021) 138 (Supplement 1): 1535.

https://doi.org/10.1182/blood-2021-149630

Published: 2021

Journal Articles

A Study of Ribonucleotide Reductase mRNA Expression and Its Prognostic Role in Patients with Chronic Lymphocytic Leukemia

Sevastianos Chatzidavid, Christina-Nefeli Kontandreopoulou, Panagiotis T Diamantopoulos, Nefeli Giannakopoulou, Panagiota Katsiampoura, Christos Stafylidis, Georgios Dryllis, Marie-Christine Kyrtsonis, Maria Dimou, Panagiotis Panagiotidis, Nora-Athina Viniou

Blood (2021) 138 (Supplement 1): 4678.

https://doi.org/10.1182/blood-2021-150149

Published: 2021

Journal Articles

Bone Marrow Ribonucleotide Reductase mRNA Levels and Methylation Status As a Prognostic Factor in Patients with Myelodysplastic Syndrome Treated with 5-Azacytidine

Christina-Nefeli Kontandreopoulou, BSc, Panagiotis T Diamantopoulos, MD PhD, Argiris Symeonidis, MD PhD, Ioannis Kotsianidis, Vassiliki Pappa, MD, Athanasios Galanopoulos, MD PhD, Andreas Giannopoulos, BSc, MSc, Katerina Zoi, PhD, Maria Dimou, MD PhD, Elena E. Solomou, MD, Panayiotis Panayiotidis, MD, Georgios Kyriakakis, Nefeli Giannakopoulou, Georgios Dryllis, Sevastianos Chatzidavid, Nora-Athina Viniou, MD PhD

Blood (2019) 134 (Supplement_1): 1721.

https://doi.org/10.1182/blood-2019-126426

Published: 2019

Journal Articles

Estimated Glomerular Filtration Rate Is an Independent Predictor of Outcome in High-Risk Myelodysplastic Syndrome (MDS) and Low Blast Count Acute Myeloid Leukaemia (AML) Patients Treated with Azacytidine (AZA). a Retrospective Study from the MDS Registry of the Hellenic MDS Study Group

Blood (2019) 134 (Supplement_1): 5423.

https://doi.org/10.1182/blood-2019-125806

Published: 2019

Journal Articles

The Prognostic Significance of Monocytopenia in Patients with Myelodysplastic Syndrome

Panagiotis T Diamantopoulos, MD PhD, Vassiliki Pappa, MD, Nora-Athina Viniou, MD PhD, Ioannis Kotsianidis, Alexandra Kourakli, MD PhD, Argiris Symeonidis, MD PhD, Sotirios Papageorgiou, MD PhD, Elena E. Solomou, MD, Anastasia Pouli, MD PhD, Panagiotis Panagiotidis, MD PhD, Maria Dimou, MD PhD, Kalliopi Zafeiropoulou, Stamatis J. Karakatsanis, MD MSc, Anna Vardi, MD PhD, Theodoros P. Vassilakopoulos, MD PhD, Dimitrios Tsokanas, George Drakos, Spyros Hontropoulos, Eleftheria Hatzimichael, Aikaterini Megalakaki, Panagiotis Repousis, MD, Maria Kotsopoulou, Georgia Kaiafa, MD, Menelaos Konstantinos Papoutselis, Anastasia Sioni, Nikolaos Charchalakis, PhD, Eleni Bouronikou, Georgios Vasilopoulos, Vasileios Lazaris, Maria Spiliotopoulou, Flora Kontopidou, Christos K. Kontos, PhD, Stamatina Kalyva, Apostolos Hatzitolios, Helen A. Papadaki, MD PhD, Achilles Anagnostopoulos, Nikolaos Anagnostopoulos, Athanasios Galanopoulos, MD PhD

Blood (2019) 134 (Supplement_1): 5427.

https://doi.org/10.1182/blood-2019-127417

Published: 2019

Journal Articles

Prognostic Significance of Bone Marrow Cellularity in the Outcome of Patients with Myelodysplastic Syndromes Treated with Azacyitidine: A Retrospective Analysis from the Hellenic MDS Study Group

Elena E. Solomou, MD, Alexandra Kourakli, MD PhD, Anna Vardi, MD PhD, Ioannis Kotsianidis, MD PhD, Panagiotis Zikos, MD, Vassiliki Pappa, MD, Athanasios Galanopoulos, MD PhD, Aikaterini Palla, Athina Vyniou, Charalampos Pontikoglou, MD PhD, Panagiotis T Diamantopoulos, MD PhD, Theodoros Vassilakopoulos, MD, Aikaterini Megalakaki, Eleni Variami, Helen A. Papadaki, MD PhD, George Vassilopoulos, MD PhD, Achilles Anagnostopoulos, Argiris Symeonidis, MD PhD

Blood (2019) 134 (Supplement_1): 5417.

https://doi.org/10.1182/blood-2019-131003

Published: 2019

NARROW

Immunogenicity and Safety of the Recombinant Adjuvanted Herpes Zoster Vaccine in Patients with Chronic Lymphocytic Leukemia and Multiple Myeloma

Real-Life Experience of Luspatercept in Transfusion-Dependent Lower-Risk Myelodysplastic Syndrome Patients

Illness Perceptions and Heath Related Quality of Life in Patients with Primary Immune Thrombocytopenia

A Single-Center Study of Long-Term Efficacy and Discontinuation Patterns of Thrombopoietin Receptor Agonists in Chronic Immune Thrombocytopenia

The Prognostic Significance of Serum Beta-2 Microglobulin (sβ 2 m) Levels in Patients with Hodgkin Lymphoma (HL): Final Analysis on 915 Patients Treated with ABVD or Equivalent (ABVDeq) Chemotherapy or Combined Modality Therapy (CT/CMT) Focusing to the Determination of Optimal Cut-Offs

Micrornas Analysis in Patients with Myelodysplastic Syndrome. Possible Implications in Risk Stratification

Evidence That Platelets from Transfusion-Dependent Thalassemia Patients Induce T Cell Activation

The Transcription Factor ETS-1 Correlates with the Increased Age Associated B Cells in Patients with Acquired Aplastic Anemia

Myelodysplastic Syndromes (MDS) Presenting with Isolated Thrombocytopenia: Characteristics, Outcomes, and Clinical Presentation Differences from Immune Thrombocytopenic Purpura (ITP)

A Study of Ribonucleotide Reductase mRNA Expression and Its Prognostic Role in Patients with Chronic Lymphocytic Leukemia

Bone Marrow Ribonucleotide Reductase mRNA Levels and Methylation Status As a Prognostic Factor in Patients with Myelodysplastic Syndrome Treated with 5-Azacytidine

Estimated Glomerular Filtration Rate Is an Independent Predictor of Outcome in High-Risk Myelodysplastic Syndrome (MDS) and Low Blast Count Acute Myeloid Leukaemia (AML) Patients Treated with Azacytidine (AZA). a Retrospective Study from the MDS Registry of the Hellenic MDS Study Group

The Prognostic Significance of Monocytopenia in Patients with Myelodysplastic Syndrome

Prognostic Significance of Bone Marrow Cellularity in the Outcome of Patients with Myelodysplastic Syndromes Treated with Azacyitidine: A Retrospective Analysis from the Hellenic MDS Study Group

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only